Genotypes and allelic frequencies of TPH2, 5-HTTLPR, the 5-HTT (SLC6A4) intron 2 variable-number tandem repeat (VNTR) region, and the MAOA VNTR region were determined in brain-stem samples of 20 "genuine" SIDS cases and compared with results obtained from 150 healthy controls. The SNP G1463A responsible for 80% functionality loss of TPH2 (tryptophan hydroxylase 2) was not detected, neither in SIDS infants nor in the controls. In contrast, a strict relation was found between the 5-HTTLPR genotype and its allelic frequencies with SIDS cases. The L/L genotype and the long allele (L) of the promoter region of the serotonin transporter were significantly associated (likelihood ratio (LR) test, p b 0.001) with the syndrome (L/L, 60% SIDS vs 14% controls; L, 80% SIDS vs 42.6% controls). Polymorphisms of the intron 2 VNTR of the same gene showed a trend for significant differences between genotypes 10/10 and 12/12 (LR test, p = 0.068), with the L-12 haplotype being almost twofold in SIDS (44.5%) with respect to controls (23.4%). Differences were even higher considering the genotype combination L/L-12/12 (20% SIDS vs 2.6%), and variations among categories were statistically highly significant (p b 0.001). Although additional differences were observed in the frequency of the MAOA (monoamine oxidase A) VNTR genotype 3R/3R between SIDS and controls (respectively 15% vs 26%), the results were not supported by statistical significance. Molecular polymorphisms are discussed considering their functional role in regulating serotonin synthesis (TPH2), neuronal reuptake (5-HTTLPR and 5-HTT intron 2), and catabolism (MAOA) in the nervous system of Italian SIDS infants. Comparisons are made with previous data obtained in different ethnic groups.
Sudden infant death syndrome (SIDS) is defined as the sudden death of an infant, within 1 year of age, that is unexpected by history and for which a full postmortem examination, including in-depth examination of the autonomic nervous system, fails to demonstrate a possible cause of death [1] . Excluding the neonatal period, the syndrome is the most common cause of infant death in developed countries. The incidence of SIDS in Italy is about 0.70/1000 live births each year but only a marginal number of these deaths are diagnosed and fully investigated (the number of live births was 562,600 in 2004 (www.populationeurope.org) and about 400 deaths probably occurred that year). To fulfill diagnostic and scientific gaps, the Italian national government has recently passed a law (No. 31; February 2, 2006) with the aim of increasing necroscopic investigations and acquiring additional scientific knowledge on this syndrome. As a matter of comparison, the SIDS incidence rate in the United States was in the range 0.67-0.80/1000 births in the same period [2, 3] and was much lower in Japan, with 0.24/1000 births [4] .
Although SIDS has been known since ancient times (Bible, 1 Kings, chapter 3, 19) , its etiopathogenesis mechanisms are still obscure. A possible contribution of genetic factors has long been denied but recent advances in molecular genetics have opened new perspectives in the definition of pathogenic mechanisms of SIDS. Since the first studies on genes involved in metabolic disorders occasionally responsible for unexpected perinatal deaths [5] , additional associations between DNA markers, risk factors, and SIDS have been demonstrated [6] [7] [8] [9] [10] . In addition, a population genetic component also emerges when analyzing the SIDS incidence in different ethnic groups [11] and particularly the relevant values of small bottlenecked populations such as the Native Americans and the Maori [12, 13] .
Among the variety of genes investigated during the past decade, several studies have identified polymorphisms in the serotonin transporter (5-HTT) (SLC6A4 encoding 5-HTT) as a predisposing factor in infant death [9, 14] . A notable finding was the increased frequency of the long allele (L) of the promoter region of the gene in specific populations, consistent with the patterns of SIDS prevalence in the different ethnic groups. Narita et al. [15] identified an association between the long allele of 5-HTT and SIDS in a small Japanese cohort. Weese-Mayer et al. [16] confirmed this association in a larger sample of American SIDS cases. Furthermore, an association between SIDS and the L-12 haplotype ("long" promoter allele and "12" allele of intron 2 of the same gene) was found in the African-American population [17] . The ethnic disparity observed within the American population was recently confirmed by the detection of rare mutations occurring in the FEV gene expressed in central 5-HT neurons [18] . To understand whether serotonin is the real key factor in SIDS, Weese-Mayer et al. [9] have recently emphasized the need to assess allelic frequencies of the 5-HTT promoter region and the intron 2 variable-number tandem repeat (VNTR) region in several countries to obtain a broader view of the role of the serotonin transporter in different SIDS populations and its correlation with phenotypic characters. Since the distribution of 5-HTT alleles and genotypes varies among subjects of different ethnicities, the degree of association of the polymorphisms with SIDS may also be different.
Considering the functional involvement of serotonin in SIDS and the recent evidence of multiple serotoninergic brain-stem abnormalities in the syndrome [2, 19] , which may be linked to additional genes regulating the neurotransmission pathway, we carried out an investigation to define the involvement of three genes influencing serotonin metabolism in both the autonomic and the central nervous systems (Fig. 1) . Polymorphisms of two different 5-HTT regions (5-HTTLPR, hydroxytryptamine transporter-linked polymorphic region, and Stin2, intron 2 VNTR), the promoter region of MAOA (monoamine oxidase A), and TPH2 (tryptophan hydroxylase 2) were investigated in an Italian SIDS population and controls. The serotonin 3′ UTR single-nucleotide polymorphism (SNP) was not considered in this work since a recent investigation demonstrated that this polymorphism does not influence the SIDS risk [20] . With respect to previous papers dealing with serotonin involvement in SIDS, this is the first investigation considering two additional genes influencing the 5-HTT action in the neurotransmission pathway. In fact, monoamine oxidase A is a mitochondrial enzyme that regulates serotoninergic signals through catabolism of vesicular serotonin in the presynaptic region, while TPH-2 regulates the first step of serotonin synthesis inside the presynaptic neuron ( Fig. 1 ). An upstream variable number of tandem repeats within the MAOA promoter region (MAOA-u VNTR) was related to the transcriptional efficiency of the gene [21] , while Zhang et al. [22] identified a missense mutation (G1463A) that causes about 80% of function loss in the neuronal-specific TPH2, which could have significant physiological consequences for brain serotonin synthesis.
Genotypes and allelic frequencies of 5-HTTLPR, intron 2 VNTR, MAOA-u VNTR, and TPH2 were therefore determined in 20 SIDS cases and compared with data obtained in 150 healthy controls. Infants were also genotyped for mutations carried by SCN5A to exclude the long-QT syndrome [23] (data not shown). Genetic results are discussed with respect to a possible serotonin pathway in the nervous system of SIDS infants also considering possible population or ethnicity differences. Emphasis has been put on the functional role of the different polymorphisms in regulating serotonin synthesis (TPH2), neuronal reuptake (5-HTTLPR and 5-HTT intron 2), and catabolism (MAOA) in the brain stem.
Results

TPH2-tryptophan hydroxylase 2
The SNP G1463A responsible for the R441H mutation was investigated by sequence analysis of 720 bp of exon XI. Within this DNA region, 650-bp amplicons were compared between 20 SIDS infants and 50 controls. No polymorphisms were found and 100% identity resulted between pathologic and nonpathologic samples. The G1463A SNP was not detected in any of the pathologic samples nor in the controls.
5-HTT-serotonin transporter
Two different regions of serotonin transporter were investigated: the so-called 5-HTT-linked polymorphic region of the promoter and VNTR polymorphisms of intron 2. Frequencies of genotypic and allelic data for both gene regions are reported in Table 1 .
Both short (S) and L alleles of the promoter region were found. In particular, 12 homozygote genotypes, L/L, and 8 heterozygotes, S/L, were detected in the 20 investigated SIDS infants. The frequency of the L/L genotype was much higher in SIDS cases (60%) than in the controls (14%), while the frequency of the S/L genotype was similar in the two groups (40% vs 57.3%). Interestingly, no infant affected by the syndrome had the S/S genotype (0% SIDS vs 28.7% controls). The statistical significance of overall genotype differences between SIDS and controls was defined by LR 2df = 10.39 (p = 0.001). Considering allelic frequencies, the L allele was 80% in SIDS infants and 42.6% in the controls (LR 1df = 12.36, p b 0.001).
Polymorphisms of the VNTR of intron 2 are also important due to their functional role in gene expression. According to Weese-Mayer et al. [17] the frequencies of the 12/12 genotype and 12 allele should be significantly different between AfricanAmerican and Caucasian cases. Genotypes 10/12 and 12/12 were detected in Italian SIDS infants. No infant with genotype 10/10 emerged from among 20 investigated cases. From a statistical point of view, Stin2 polymorphisms showed a trend of significant differences between genotypes 10/10 + 10/12 and 12/ 12 (LR 1df = 3.33, p = 0.068). This tendency seemed influenced by the limited number of African-Italian SIDS in our dataset. Real differences between ethnicities within the Italian population could not be assessed since our SIDS cohort was constituted by 19 Caucasian subjects and only 1 African Italian. It must be remarked that this last case was L/L and 12/12, the combined genotypes associated with increased SIDS death in the African-American population [17] . Although genotype differences were observed between SIDS cases and matched controls, the frequencies of the 10 and 12 alleles were exactly the same in the two groups. A combined analysis of the 5-HTT promoter and intron 2 variants was also performed for the total dataset considering the previously defined significant linkage disequilibrium of the two gene regions [17] . The haplotype analysis demonstrated that the L-12 haplotype was almost twofold in SIDS (44.5%) with respect to matched controls (23.4%). Differences were even higher considering genotype combinations L/L-10/12 (40% SIDS vs 8.7% controls) and L/L-12/12 (20% SIDS vs 2.6% controls). Comparisons among categories resulted in highly significant differences (p b 0.001) for both genotype and haplotype combinations. Data for promoter and Stin2 combinations are presented in Table 2 .
MAOA-monoamine oxidase A
Three variants of the MAOA-u VNTR polymorphism were detected within the promoter region. Alleles defined by 3 (320 bp), 3.5 (335 bp), and 4 (350 bp) repeats consistent with allelic nomenclature [24] were identified in 20 SIDS samples and the 150 controls. Alleles 2.5R and 5R were not noticed.
Data on genotype and allele frequencies of MAOA are reported in Table 3 . The frequency of genotype 3R/3R was higher in the controls (26%) with respect to SIDS infants (15%). Some difference also emerged for genotype 3.5R/4R even though this genotype was scarcely represented in our investigation (2.6-5.0%). Genotypes 3R/4R and 4R/4R showed only marginal differences. Considering allelic frequencies, VNTR-3 was lower in SIDS (30.0%) than the controls (40.3%).
Despite differences in the genotype distribution and allelic frequencies between SIDS and controls, no statistical significance emerged for this gene (p values in the range 0.37-0.39).
Discussion
Although the serotoninergic system is complex, the serotonin transporter (5-HTT) is a major determinant of serotoninergic function through modification of gene transcription and transporter expression [20, 25, 26] . As a genetic factor, the polymorphisms of 5-HTT appear important for the etiology of SIDS [9] . Two common polymorphisms of this gene have been identified, a 44-bp insertion/deletion polymorphism in the upstream regulatory region (5-HTTLPR) and a VNTR polymorphism in the second intron (Stin2) [25] . In the promoter region it was demonstrated that two allelic variants (S and L) differentially modulate transcription of the 5-HTT gene, with the L variant being more efficient [25] ; as well, it has been suggested that the VNTR region may act as a transcriptional regulator with the 12-repeat allele having stronger enhancer-like properties than the 10-repeat allele [26] . In this study the frequency of the L/L genotype was over fourfold higher in SIDS infants than in controls (60 vs 14%). Considering allelic frequencies, the L allele was twofold higher in SIDS infants with respect to controls (80 vs 42.6%). Comparisons between pathologic and nonpathologic samples reached high statistical significance at both the genotype (p = 0.001) and the allelic level (p b 0.001). Interestingly, no SIDS infants with the S/S genotype were observed among our 20 investigated cases. Genotype and allele distributions for intron 2 did not differ significantly between SIDS and controls over the entire dataset. Although a statistical trend (p = 0.068) was observed in the genotype distribution, the occurrence of the 12/12 genotype was lower in pathologic samples than controls. The frequencies of the 10 and 12 alleles were exactly the same in the two groups. Despite this, a significant association emerged between SIDS and the combined genotypes L/L-10/12 and L/L-12/12 with respect to controls (p b 0.001). In addition, a haplotype analysis performed considering both 5-HTTLPR and intron 2 VNTR alleles demonstrated that the L-12 haplotype was associated with increased SIDS risk. In fact, the haplotype percentage was almost twofold in our SIDS cases (44.5%) with respect to matched controls (23.4%). A major contribution to the association was due mainly to the L allele (p b 0.001).
Despite the ethnic variability in the 5-HTT promoter polymorphisms data [27] that might provide insight into the remarkable disparities in SIDS incidence in different populations, it is interesting to observe that our results are in agreement with previously published data in the Japanese [15] and American [16] SIDS populations. In fact, Narita et al. [15] observed an L/L genotype frequency of 18.5% (Japanese SIDS) vs 2.6% (Japanese controls), while Weese-Mayer et al. [16, 17] found 40.9% in SIDS vs 27.3% in controls considering the Caucasian population of North America. Similar to Narita et al. [15] and Weese-Mayer et al. [16] , the L allele frequency was twice in our SIDS population with respect to controls. These data are an important confirmation of previous considerations by WeeseMayer et al. [9, 16] stating that, despite ethnic variation in the frequency of the L allele, SIDS cases were more likely than controls to have the long allele. As concerns intron 2, although genotype and allele distribution did not differ significantly between SIDS and controls, the results were in agreement with the only previously published data by Weese-Mayer et al. [17] that found no differences between SIDS and controls in the Caucasian population but did find differences in the African- [17] . Two additional genes were investigated to address synergic interactions within the neuronal transmission. In particular, tryptophan hydroxylase (TPH-1 and TPH-2) is the rate-limiting enzyme in 5-HT synthesis and in contrast to TPH1, which controls most peripheral 5-HT synthesis, TPH2 was recently found to be neuronal specific and predominantly expressed in brain serotoninergic neurons originating from raphe nuclei [28] . In this work we investigated an SNP in human TPH2 that results in 80% loss of function in serotonin production [22] . Neither the SNP G1463A responsible for the R441H mutation nor additional polymorphisms were detected in SIDS infants and healthy controls, confirming the highly conserved sequence of the gene. Considering the low recurrence of this point mutation in the population [22] , a possible role for TPH2 in the syndrome pathogenesis could therefore be only occasional. To complete the serotonin pathway, an upstream VNTR within the MAOA promoter region [24] was also investigated. It consists of a 30-bp repeat sequence consisting of 3, 3.5, 4, or 5 copies, and expression studies indicate that the number of repeats is related to the transcriptional efficiency of the gene, such that the threerepeat allele is associated with reduced gene expression and, hence, reduced activity, relative to the other alleles [21, 29] . In this investigation, a difference of genotype 3R/3R distribution between SIDS and controls was observed. Although with low frequencies, the genotype value was higher in the healthy controls (26%) than in SIDS infants (15%) but results did not reach statistical significance. With respect to previously published data obtained in healthy individuals belonging to different ethnic groups, our results are in strict agreement with those of Deckert et al. [30] . In Deckert's paper the frequency of alleles 3R and 4R determined in the general Italian population was exactly the same as in our investigated control cohort. Therefore, it can be hypothesized that the observed differences in allele 3R between SIDS cases and controls are real and could play a certain role in the syndrome pathogenesis. Unfortunately, one of the main limitations of this result is the limited SIDS sample size. It must also be remarked this is the first report on the MAOA-u VNTR polymorphism in a cohort of SIDS infants and functional considerations will have to be assessed further in a larger sample.
In conclusion, this paper highlights the importance of genetic studies to define etiopathogenesis mechanisms of SIDS and points out the role of the serotonin transporter by confirming the involvement of 5-HTT polymorphisms in the Italian SIDS population. The consistent finding of this genetic investigation in a country different than those previously investigated provides additional knowledge for a better understanding of ethnic disparities and SIDS.
Materials and methods
Twenty SIDS victims (10 females and 10 males), 2 days to 7 months of age, were selected for this study after a complete postmortem investigation performed according to pathologic and forensic criteria [31] . It is noteworthy that 17 infants died within the third month of age, while only 3 passed between 5 and 7 months of age. Brain-stem tissues of SIDS victims were sectioned at the level of the arcuate nucleus (medulla oblongata) and conserved as either fresh ethanol-fixed or paraffin-embedded tissues. In addition, whole blood or urine samples were obtained from 150 healthy subjects (80 females and 70 males) older than 1 year to be used as controls.
Genomic DNA was extracted from autoptic fresh tissues using the Aqua Pure Genomic DNA Kit (Bio-Rad Laboratories) following the producer's instructions. Paraffined tissues were heated and treated with xylol to eliminate paraffin, according to the optimized protocol proposed by Shi et al. [32] . In particular, deparaffination was carried out on five slices of 10-µm thickness obtained from each paraffin block. After deparaffination, DNA was extracted and purified using a standard proteinase K/SDS-phenol/chloroform method [33] . Extraction yield ranged approximately from 1000 to 10,000 ng. The use of fresh (frozen) tissue is certainly recommended since extraction from paraffinembedded samples was not always successful. In fact, 10 samples were discharged after DNA extraction and only 4 were suitable for DNA amplification.
DNA was extracted from 200 µl of whole-blood samples of healthy controls using the Charge Switch gDNA Blood Kit (Invitrogen). Urine samples were used to avoid blood collection from children [34] . About 100 ml of first morning urine was collected and centrifuged at 15,000 rpm. Sedimented cells were then pipetted and submitted to DNA extraction carried out by means of a QIAmp DNA Blood Mini Kit (Qiagen).
Amplification reactions and conditions were the following: TPH2 was amplified by PCR (thermal cycler MJ Research PTC100) to detect the G1463A polymorphism using primers reported by Zhang et al. [22] : forward, 5′-ATGCCTTATCACCACCTTCC-3′, and reverse, 5′-TTAGATCTGAAAAA-GAAAAGGGC-3′). The first PCR was performed in a total volume of 25 µl containing 30 ng of genomic DNA, 0.2 mM dNTPs, 10 pmol of forward and reverse primers, 1× reaction buffer, 1.5 mM Mg 2+ , and 1 U of GoTaq DNA polymerase (Promega, Madison, WI, USA). PCR conditions were developed in a touchdown reaction consisting of 3 cycles at annealing temperature, 52, 50, and 48°C followed by 30 cycles at 50°C. PCR products of 720 bp were purified and genotyped by both forward and reverse sequencing. Gel band purification was performed using the GFX PCR DNA Kit (Amersham Biosciences), while sequencing PCR was carried out using the CEQ DTCS-Quick Start Kit (Beckman Coulter), and products were loaded on a CEQ 8000 automatic sequencer (Beckman Coulter). Nucleotide sequences were compared to those available in genomic databases using BLAST and FASTA. Multiple alignments of sense and antisense sequences were conducted using the softwares CLUSTALX, Sequencher, and Genedoc.
MAOA-u VNTR was typed using primers suggested by Cohen et al. [29] : forward, 5′-ACAGCCTGACCGTGGAGAAG-3′, and reverse, 5′-GAACG-GACGCTCCATTCGGA-3′. The size of the amplified fragment is 350 bp for alleles with four copies of repeats. PCR amplification was conducted in a final volume of 25 µl consisting of 30 ng of genomic DNA, 0.2 mM dNTPs, 10 pmol of forward and reverse primers, 1× reaction buffer, 1.5 mM Mg 2+ , and 1 U of GoTaq DNA polymerase (Promega). Cycling conditions were 5 min at 95°C for initial denaturation; followed by 40 cycles of 1 min at 95°C, 1 min at 65°C, and 1 min at 72°C; and a final extension at 72°C for 10 min. PCR products were separated by 2.5% agarose gel electrophoresis followed by ethidium bromide staining and visualized under UV light. The various alleles were determined using the GeneRuler 100 bp DNA ladder (Fermentas, Hanover, MD, USA).
Polymorphisms of the serotonin transporter 5-HTT were investigated using specific primers for 5-HTTLPR and intron 2 VNTR. According to Gelernter et al. [27] , they were, respectively, forward, 5′-ATGCCAGCACCTAACCCCTA-ATGT-3′, and reverse, 5′-GGACCGCAAGGTGGGCGGGA-3′, for 5-HTTLPR and forward, 5′-GTCAGTATCACAGGCTGCGAG-3′, and reverse, 5′-TGTTC-CTAGTCTTACGCCAGTG-3′, for intron 2.
PCR amplification was performed in a final volume of 20 µl consisting of 30 ng of genomic DNA, 0.2 mM dNTPs, 10 pmol of forward and reverse primers, 1.5 mM Mg 2+ , 1× reaction buffer, and 1 U of GoTaq DNA polymerase (Promega). Amplification conditions for 5-HTTLPR were an initial step of denaturation at 94°C for 10 min and subsequently 35 cycles comprising 1 min at 94°C, 1 min at 66°C, and 1 min at 72°C. For the intron 2 polymorphism the annealing temperature was reduced to 56°C. Different alleles were separated on agarose gel electrophoresis following the same procedure previously reported for MAOA.
To investigate possible associations between genotypes/alleles and experimental groups, a likelihood ratio χ 2 test was performed. It is a more robust test than the classical Pearson χ 2 to deal with low-number categories such as genotype and allele groups. Statistical analyses were performed using Statistica software (version 7.1). p values were considered highly significant when lower than 0.01 and significant in the range 0.01 b p b 0.05. In addition, values in the range 0.05 b p b 0.10 were considered a trend of significance. Degrees of freedom were equal to 1 less than the number of alleles/genotypes.
